Latest News about Briefs
Recent news which mentions Briefs
Consumer Sporting Goods Company Escalade's Q4 Sales Dip, CEO Foresees Margin Boost In 2024
April 01, 2024
From Benzinga
What's Going On With Palantir Technologies Shares Monday?
April 01, 2024
From Benzinga
From Benzinga
Taiwan Semi's Strategic Japan Move: Forging Academic Ties with Kyushu University Amid Expansion
April 01, 2024
From Benzinga
Why Chinese EV Manufacturer NIO Shares Are Gaining Today
April 01, 2024
From Benzinga
Why Is Li Auto Stock Shooting Higher Today?
April 01, 2024
From Benzinga
Microsoft Decouples Teams from Office Globally in Response to Antitrust Concerns: Report
April 01, 2024
From Benzinga
BlackBerry's FY25 Revenue Guidance May Fall Short Of Expectations - Analyst Flags Weakness In Cybersecurity Unit
March 28, 2024
From Benzinga
From Benzinga
From Benzinga
Why Spotify Technology Shares Are Gaining Today
March 28, 2024
From Benzinga
Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst
March 28, 2024
From Benzinga
Amgen's Diversified Portfolio To Drive Long-Term Growth, Though Uncertainties Loom, Analyst Says
March 28, 2024
From Benzinga
Kimberly-Clark's Long Term Outlook, Cost Savings Plan Looks Encouraging, Analyst Says
March 28, 2024
From Benzinga
4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease
March 28, 2024
From Benzinga
This Analyst Raised Robinhood's Forecast By 46% - Here's Why
March 28, 2024
From Benzinga
Tesla Is Navigating Free FSD Trials, Gigafactory Challenges, and Governance Hurdles: Analyst
March 28, 2024
From Benzinga
MicroStrategy's Bitcoin Surge: How a Tech Company Outpaces eBay and Delta in Market Cap
March 28, 2024
From Benzinga
From Benzinga
Snowflake Expands Data Clean Rooms Across Clouds; CEO's Insider Buying Amid Databricks 'Competition' Buzz Sparks Attention
March 28, 2024
From Benzinga
From Benzinga
Johnson & Johnson Has An Opportunity In Talc-Cancer Lawsuit, Can Challenge Scientific Evidence In Federal Ruling
March 28, 2024
From Benzinga
How Much Does It Cost To Make Novo Nordisk's Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows
March 28, 2024
From Benzinga
From Benzinga
Extend Life Expectancy Against Aggressive Brain Cancers - Nano-Cap Firm Biodexa's Investigational Drug Shows Potential
March 28, 2024
From Benzinga
Why BuzzFeed Shares Are Surging Thursday
March 28, 2024
From Benzinga
Cancer Focused Micro-Cap Xilio Therapeutics Stock Doubles In One Session - Here's Why
March 28, 2024
From Benzinga
Hut 8 Stock Climbed After Its Results, What's Going On?
March 28, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.